[Nonglycemic effects of dipeptidyl peptidase-4 inhibitors].

A S Ametov; L L Kamynina

Found an issue? Give us feedback

Терапевтический архи...arrow_drop_down

Терапевтический архив

Article . 2013

Data sources: Europe PubMed Central

Терапевтический архив

Article . 2013

Data sources: DOAJ

[Nonglycemic effects of dipeptidyl peptidase-4 inhibitors].

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2013 Russian Publisher:"Consilium Medicum" Publishing houseJournal:Terapevticheskii arkhiv, volume 85 (issn: 0040-3660,

Copyright policy )

Authors: A S Ametov; L L Kamynina;

pmid: 23536954

[Nonglycemic effects of dipeptidyl peptidase-4 inhibitors].

- Summary
- Subjects
- Metrics

Abstract

The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.

Keywords

nonglycemic effects, Blood Glucose, Dipeptidyl-Peptidase IV Inhibitors, type 2 diabetes mellitus, R, sitagliptin, Diabetes Mellitus, Type 2, Medicine, Animals, Humans, dipeptidyl peptidase-4 inhibitors

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average